Insider Transactions in Q2 2023 at 4 D Molecular Therapeutics, Inc. (FDMT)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2023
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,750
-68.34%
|
$75,000
$20.85 P/Share
|
|
Jun 08
2023
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+40.6%
|
$30,000
$8.04 P/Share
|
|
Jun 01
2023
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,247
-56.4%
|
$40,446
$18.31 P/Share
|
|
Jun 01
2023
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+32.0%
|
$11,250
$6.49 P/Share
|
|
May 15
2023
|
August J Moretti Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+21.36%
|
$27,000
$9.41 P/Share
|
|
May 09
2023
|
Viking Global Investors LP |
BUY
Open market or private purchase
|
Indirect |
850,000
+15.08%
|
$13,600,000
$16.0 P/Share
|
|
May 02
2023
|
David Kirn Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
600,000
+50.0%
|
-
|
|
May 02
2023
|
David Kirn Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
600,000
-32.27%
|
-
|
|
Apr 21
2023
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,750
-64.0%
|
$75,000
$20.0 P/Share
|
|
Apr 21
2023
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+39.03%
|
$30,000
$8.04 P/Share
|
|
Apr 21
2023
|
Jacob Chacko |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$100,000
$20.05 P/Share
|
|
Apr 21
2023
|
Jacob Chacko |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$45,000
$9.41 P/Share
|